AbbVie
ABBV
#30
Rank
HK$3.510 T
Marketcap
HK$1,987
Share price
4.20%
Change (1 day)
37.55%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Cash on Hand

Cash on Hand as of March 2026 : HK$73.64 Billion

According to AbbVie's latest financial reports the company has HK$73.64 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AbbVie - Cash on Hand chart (from 2011 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$40.90 B-5.16%
2024-12-31HK$43.12 B-56.91%
2023-12-31HK$100.09 B38.81%
2022-12-31HK$72.10 B-5.93%
2021-12-31HK$76.65 B16.61%
2020-12-31HK$65.73 B-78.86%
2019-12-31HK$310.93 B392.57%
2018-12-31HK$63.12 B-17.46%
2017-12-31HK$76.48 B53.55%
2016-12-31HK$49.80 B-23.56%
2015-12-31HK$65.16 B0.32%
2014-12-31HK$64.95 B-15.35%
2013-12-31HK$76.72 B24.11%
2012-12-31HK$61.82 B1118.97%
2011-12-31HK$5.07 B5948.41%
2010-12-31HK$83.85 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
HK$102.54 B 39.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$41.42 B-43.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$94.40 B 28.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$33.58 B-54.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$59.94 B-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$82.23 B 11.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$60.19 B-18.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$35.75 B-51.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$10.32 B-85.98%๐Ÿ‡บ๐Ÿ‡ธ USA